Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
In recent years, transplantation immunologists working with NOD mice have discovered that they have unusual features besides their development of diabetes. NOD mice are highly resistant to tolerance induction by several different approaches, even for skin grafts and heart transplants. NOD mice also have an unusually powerful capacity to reject allografts entirely through the indirect pathway.
The experiments proposed in this application will explore the hypothesis that the development of
autoimmunity in NOD mice and their unusual transplantation traits have a common etiology involving abnormalities of their peripheral T cell regulatory mechanisms.
In the first Specific Aim we will determine the genetic basis for the resistance of NOD mice to
tolerance induction and for the unusual strength of their indirect effector response. These
experiments will use a classical immunogenetics approach to determine whether the two transplantation traits of NOD mice have a common genetic basis and whether it involves diabetes susceptibility genes.
In the second Specific Aim we will use in vitro experiments to explore the mechanisms responsible for the resistance of NOD mice to tolerance induction and for the unusual strength of their indirect effector response. These experiments will determine whether disordered peripheral regulatory mechanisms are responsible for the transplantation traits as well as the tendency of NOD mice to develop autoimmunity.
In the third Specific Aim we will perform in vivo experiments designed to explore the mechanisms
responsible for the NOD transplantation traits and to overcome their resistance to tolerance
induction and the unusual strength of their indirect effector response. Part of the purpose of these experiments is to identify therapies that might be used for patients who might be identified as having the genes responsible for the NOD transplantation phenotype.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-May-2004
Project End Date
30-April-2009
Budget Start Date
01-May-2007
Budget End Date
30-April-2008
Project Funding Information for 2007
Total Funding
$414,829
Direct Costs
$237,045
Indirect Costs
$177,784
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Allergy and Infectious Diseases
$414,829
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI054976-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI054976-04
Patents
No Patents information available for 5R01AI054976-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI054976-04
Clinical Studies
No Clinical Studies information available for 5R01AI054976-04
News and More
Related News Releases
No news release information available for 5R01AI054976-04
History
No Historical information available for 5R01AI054976-04
Similar Projects
No Similar Projects information available for 5R01AI054976-04